Forschung am Memorial Sloan-Kettering-Klinikum…erst mal ein Überblick – und auch auf Englisch. FEMINISSIMA ist im Begriff, den Schwerpunkt auf FORSCHUNG und nicht zuletzt Krebs-FORSCHUNG & TREATMENT (Behandlung) auszudehnen und zu „katalogisieren“.
Als non-profit-Online-Magazin suchen wir noch nach SPONSOREN, damit wir ÜBersetzerInnen und Fach-Mediziner…ein wenig honorieren können.
Unsere Vielsprachigkeit ist keine fachspezifische, you know. Und man möchte gerade in Medizin und Forschung nichts FALSCH übersetzen…
Included in this issue…
Clinical States Model of Prostate Cancer: Two Success Stories
Updated Prostate Cancer Pages
Why Some Lung Cancers Stop Responding to Tarceva and Iressa
CancerSmart Lecture – Breast Cancer: New Concepts, New Targets, New Directions, New Hope
CancerSmart Lecture – Skin Cancer From A-Z: Risk Factors, Diagnosis, and Treatment
CancerSmart Lecture – What You Should Know About Thyroid and Bladder Cancers
Free Head and Neck Cancer Screenings
Clinical States Model of Prostate Cancer: Two Success Stories
At Memorial Sloan-Kettering, prostate cancer treatment decisions are based on a dynamic clinical states model, in which physicians define therapeutic goals for each prostate cancer patient at the time of diagnosis, redefining them to meet the patient’s needs as the disease unfolds. To give a human context to this model, our newly updated prostate cancer Web resource section features the inspiring stories of two men, each of whom has confronted prostate cancer in his own way.
more
WHAT’S NEW AT MSKCC.ORG
Updated Prostate Cancer Pages
These pages provide an overview of prostate cancer, including information on risk factors, symptoms, screening, diagnosis, treatment, and life beyond treatment.
more
RESEARCH AT MEMORIAL SLOAN-KETTERING
Why Some Lung Cancers Stop Responding to Tarceva and Iressa
Researchers at Memorial Sloan-Kettering have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa). This discovery may lead to the development of new therapies to use when these agents stop working.
more
PUBLIC EDUCATION
CancerSmart Lecture – Breast Cancer: New Concepts, New Targets, New Directions, New Hope
On Tuesday, March 22, join Memorial Sloan-Kettering’s Deputy Physician-in-Chief for Breast Cancer Programs, Larry Norton, MD, as he discusses all aspects of breast cancer.
more
CancerSmart Lecture – Skin Cancer From A-Z: Risk Factors, Diagnosis, and Treatment
On Tuesday, April 12, join Memorial Sloan-Kettering physicians — Allan C. Halpern, Chief, Dermatology Service; Kishwer S. Nehal, Assistant Attending Physician, Dermatology Service; and Jedd D. Wolchok, Assistant Attending Physician, Clinical Immunology Service — for our annual update on developments in skin cancer.
more
CancerSmart Lecture – What You Should Know About Thyroid and Bladder Cancers
On Thursday May 5th, join Memorial Sloan-Kettering physicians — Steven M. Larson, Chief, Nuclear Medicine Service; Robert Michael Tuttle, Associate Attending Physician, Endocrinology Service; and S. Machele Donat, Associate Attending Surgeon, Department of Urology — for an overview on thyroid and bladder cancers.
more
FREE CANCER SCREENING
Free Head and Neck Cancer Screenings
Free head and neck cancer screenings will be held Friday, April 15, from 1:00 PM to 5:00 PM. No appointment is necessary. The screening will include a ten-minute exam by doctors at Memorial Sloan-Kettering to look for signs of head and neck cancer. Smoking cessation counseling and advice on cancer preventive diets will also be provided.
For more information call: 646-497-9161. Location: Memorial Sloan-Kettering’s Enid A. Haupt Pavilion, 425 East 67th Street, 4th floor, Suite 5.
Un-Subscribe Subscribe Change Email Settings
(c) 2005 Memorial Sloan-Kettering Cancer Center – www.mskcc.org